Tag: AAV

Rewriting the Code: How AI is Transforming Viral Vector Design

In the rapidly advancing world of cell and gene therapy, viral vectors have become the molecular vehicles driving transformative treatments forward. These engineered viruses—most commonly Adeno-Associated Viruses (AAVs) and Lentiviruses (LVs)—are designed to deliver therapeutic genetic material into human cells, enabling everything from gene replacement and silencing to reprogramming immune cells in the fight against […]